Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

Vilon: Evidence Summary

Evidence summary for Vilon across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.

Back to Vilon overview
Indication Evidence Tier Trial Count Summary
Immune modulation Tier D 0 No human trials exist; animal studies from Russian sources report improved immune parameters but remain unverified
Thymus support Tier D 0 Rodent data suggests thymic effects but no human translation has been attempted